Finish clinical trials faster with AI agents
Delays compound. Double Blind Bio deploys AI agents inside site and sponsor workflows to reduce friction at every stage: Site selection, startup, execution, so medicines reach patients sooner.
AI agents embedded where trials slow down
Our agents map to the moments in the clinical trial lifecycle where delays compound: site selection, startup, and execution, and automate work to keep timelines on track.
Product Deep Dive
Find the right sites.
Start trials faster.
Site Selection + Feasibility
Surface sites matched to your protocol based on therapeutic experience, patient access, and enrollment track record. Get a ranked shortlist with the reasoning behind every pick, not a spreadsheet to sort through.
Study Startup
Run the full pipeline from NDA through feasibility, budgeting, and contracting in one place. AI generates protocol-specific questionnaires, scores responses against your ideal site profile, and follows up with sites automatically so nothing stalls.
Site Engagement
One workspace for site communication, document routing, and status tracking once the trial is live. Phase transitions trigger the next set of actions, so nothing falls through as you scale from 10 sites to 100.
